Beijing News–36 Types of Non-NIP Vaccines, Few Included in Local Immunization Program
On April 25th, The Beijing News ran a special two-page feature on China’s Immunization Program, showcasing the critical work of the Innovation Lab for Vaccine Delivery Research (VaxLab). The coverage included an in-depth interview with VaxLab Director Professor Tang Shenglan, along with highlights of the lab’s influential Policy Briefing Series and groundbreaking research by VaxLab partner Professor Hai Fang’s team at Peking University.
More in the report:https://m.bjnews.com.cn/detail/168238465314208.html
Caijing · Health: Which Is the Next Free Vaccine for All?
Caijing · Health featured insights from Professor Shenglan Tang’s interview on China’s National Immunization Program, supported by model estimation data from VaxLab’s research partners—Professors Hai Fang (Peking University) and Weibing Wang (Fudan University).
More in the report: https://mp.weixin.qq.com/s/723smNF3lDHYdKsykeS3nw
Yicai: Investigating the Explanations for the Omission of Four WHO-Recommended Vaccines from China’s National Immunization Program
In an interview with Yicai, Professor Shenglan Tang discussed the criteria and recommendations for adding new vaccines to China’s National Immunization Program. Using pneumococcal disease as an example, Professor Weibing Wang highlighted the key factors involved in this decision-making process—including disease burden, vaccine efficacy, and healthcare system capacity.
More in the report: https://m.yicai.com/news/101739955.html
